LG Life Sciences has developed and commercialized an array of pharmaceuticals over the years. From Interferon in 1989 (Intermax-gamma) and 1992 (Intermax-alpha), to Hepatitis B vaccine in 1992
(EUVAX B™), and recently next-generation quinolone antibiotic (FACTIVE®) was approved by the FDA in the United States.
To this end, LGLS is expanding its strategic alliances and fostering its capabilities to identify candidate drugs for development. Indeed, the company’s development of new medicines is accelerating and marketing competencies are being focused on advanced markets.
Visvero modelled the analytics framework for market share analysis and productivity analysis at the sales person, geography, pharmacy and doctor level. We created dashboards for daily analysis of field sales data and “white space” opportunities that had a high demand potential.
Technology consulting and IT outsourcing does not have to mean the same thing.
Our mission is to be a reliable long term partner to make your organization self reliant.
Our methodology is based on Agile principles, focused on strategic incremental success steps en-route to the project delivery.
2121 Noblestown Rd. Pittsburgh, PA 15205, USA
+1 (412) 539 0800